A detailed history of Simplex Trading, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 7,653 shares of NKTX stock, worth $34,591. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,653
Holding current value
$34,591
% of portfolio
0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$5.27 - $10.82 $40,331 - $82,805
7,653 New
7,653 $45,000
Q4 2023

Feb 02, 2024

BUY
$1.31 - $6.6 $8,648 - $43,573
6,602 Added 58.55%
17,877 $117,000
Q3 2023

Nov 01, 2023

BUY
$1.39 - $2.29 $8,645 - $14,243
6,220 Added 123.05%
11,275 $15,000
Q2 2023

Aug 04, 2023

BUY
$2.19 - $5.17 $7,601 - $17,945
3,471 Added 219.13%
5,055 $11,000
Q1 2023

Apr 27, 2023

SELL
$3.37 - $6.3 $2,086 - $3,899
-619 Reduced 28.1%
1,584 $5,000
Q4 2022

Feb 02, 2023

BUY
$5.14 - $14.35 $11,323 - $31,613
2,203 New
2,203 $13,000
Q2 2022

Aug 03, 2022

SELL
$7.77 - $19.44 $17,086 - $42,748
-2,199 Reduced 25.1%
6,561 $80,000
Q1 2022

May 02, 2022

BUY
$8.66 - $14.99 $64,032 - $110,836
7,394 Added 541.29%
8,760 $99,000
Q3 2021

Oct 28, 2021

BUY
$26.67 - $38.76 $5,334 - $7,752
200 Added 17.15%
1,366 $41,000
Q2 2021

Aug 12, 2021

BUY
$23.94 - $36.68 $27,914 - $42,768
1,166 New
1,166 $36,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $220M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.